Brief: Chordate's Study On Chronic Migraine To Resume Patient Recruitment
Oct 23 (Reuters) - Chordate Medical Holding publ AB
CMHM.NGM :
* ONGOING CLINICAL STUDY ON CHRONIC MIGRAINE HAS RECEIVED
THE
GO-AHEAD FROM STUDY CLINICS IN FINLAND TO RESUME PATIENT
RECRUITMENT, PAUSED DUE TO COVID-19
Source text for Eikon: ID:nBQN5QHSvQ
Further company coverage: CMHM.NGM
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Chordate Medical Holding AB (publ)
See all newsBrief: Chordate Applies For Delisting
Brief: Chordate Medical Holding Says Last Day Of Trading Is In March 2026
Brief: Chordate Medical To Enter Into Voluntary Liquidation
Brief: Chordate Board Proposes AGM To Resolve On Voluntary Liquidation And Delisting
Brief: Chordate Medical Holding Q2 Net Loss SEK 5.2 Mln